Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

7 Dec 2012 14:17

Tate & Lyle PLC

Director/PDMR Shareholding

Tate & Lyle PLC (the "Company") was informed today that on 7 December 2012, the following Persons Discharging Managerial Responsibility ("PDMR") were granted options to purchase ordinary shares of 25p each under the Tate & Lyle Sharesave Plan 2011 at an exercise price of 607 pence per share:

Name Role No. of shares subject to option Exercisable period
Tim Lodge Executive Director 2,471 1 March 2018 - 31 August 2018
Robert Gibber PDMR 1,482 1 March 2016 - 31 August 2016

This notification is made in accordance with DTR 3.1.4R (1) (a) of the FSA's Disclosure and Transparency Rules.

Lucie Gilbert

Company Secretary

7 December 2012

Copyright Business Wire 2012

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.